دورية أكاديمية
Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
| العنوان: | Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients |
|---|---|
| المؤلفون: | Begoña de las Heras, Adam Daehnke, Kamal S Saini, Melissa Harris, Kenneth Morrison, Ariel Aguilo, Isagani Chico, Laura Vidal, Robin Marcus |
| المصدر: | Digital Health, Vol 8 (2022) |
| بيانات النشر: | SAGE Publishing, 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Computer applications to medicine. Medical informatics |
| مصطلحات موضوعية: | Computer applications to medicine. Medical informatics, R858-859.7 |
| الوصف: | As a result of the unprecedented challenges imposed by the COVID-19 pandemic on enrollment to cancer clinical trials, there has been an urgency to identify and incorporate new solutions to mitigate these difficulties. The concept of decentralized or hybrid clinical trials has rapidly gained currency, given that it aims to reduce patient burden, increase patient enrollment and retention, and preserve quality of life, while also increasing the efficiency of trial logistics. Therefore, the clinical trial environment is moving toward remote collection and assessment of data, transitioning from the classic site-centric model to one that is more patient-centric. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2055-2076 20552076 |
| Relation: | https://doaj.org/toc/2055-2076 |
| DOI: | 10.1177/20552076221099997 |
| URL الوصول: | https://doaj.org/article/f9f1ec8b4c0c4b8c9c92b6de326b3709 |
| رقم الأكسشن: | edsdoj.f9f1ec8b4c0c4b8c9c92b6de326b3709 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 20552076 |
|---|---|
| DOI: | 10.1177/20552076221099997 |